TSX/CVS (TSX/CVS)

Toronto Stock Exchange: TSX/CVS · CAD

CA$21.5

-0.25 (-1.1%)· Recorded snapshot

Market cap	161.8B
Revenue (ttm)	586B
Net income (ttm)	6.9B
EPS (ttm)	CA$0.91
P/E (trailing)	23.7x
P/E (forward)	11.1x
Dividend	CA$0.63 (2.94%)
Volume	22,929

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 586B
Net income (ttm): 6.9B
EPS (ttm): CA$0.91
P/E (trailing): 23.7x
P/E (forward): 11.1x
Market cap: 161.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/CVS indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-11-04
Employees	300,000
Employees change	0
Employees growth	0%
Enterprise value	CAD 249.7B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	CA12683R1091
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	CAD 161.8B
Next earnings date	2026-11-04
Price	CAD 21.50
Price currency	CAD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	tsx/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	4.21%
EV/Earnings	36.22x
EV/EBIT	14.73x
EV/EBITDA	9.09x
EV/FCF	15.07x
EV/Sales	0.43x
FCF / EV yield	6.64%
FCF yield	10.2%
Forward P/E	11.12x
Graham number	17.52777
Graham upside	-18.66%
Lynch fair value	CAD 4.57
Lynch upside	-78.79%
P/(FCF - SBC) ratio	10.44x
P/(OCF - SBC) ratio	8.2x
P/B ratio	1.44x
P/E ratio	23.75x
P/FCF ratio	9.8x
P/OCF ratio	7.8x
P/S ratio	0.28x
Price/EBITDA ratio	6.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.88%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	CAD 26,760
Profitable quarters	3
Profitable years	7
Revenue per employee	CAD 2.3M
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -4.3B
Depreciation and amortization	CAD 6.3B
EBIT	CAD 17.3B
EBITDA	CAD 23.7B
EPS	CAD 0.91
Financing cash flow	CAD -12B
Free cash flow	CAD 16.7B
Free cash flow minus SBC	CAD 15.7B
Gross profit	CAD 80B
Income taxes	CAD 1.3B
Investing cash flow	CAD -9.7B
Net borrowing	CAD -7.3B
Net cash flow	CAD -693M
Net income	CAD 6.9B
Operating cash flow minus SBC	CAD 20B
Operating income	CAD 17.3B
Revenue	CAD 586B
Stock-based compensation	CAD 1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	CAD 88.56
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	CAD 120B
Interest coverage	3.92
Long-term assets	CAD 254.6B
Long-term liabilities	CAD 124.7B
Net cash (debt)	CAD -88.5B
Net cash / market cap	-54.09%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	CAD 38.8B
Shareholders' equity	CAD 113.5B
Tangible book value	CAD -43.2B
Tangible book value per share	CAD -33.80
Total assets	CAD 360.4B
Total cash	CAD 19.8B
Total debt	CAD 108.4B
Total liabilities	CAD 246.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current assets	CAD 105.8B
Current liabilities	CAD 122.2B
Current ratio	0.87
Inventory turnover	20.32
Net working capital	CAD -30.9B
Quick ratio	0.62
Working capital	CAD -16.6B
Working capital turnover	-38.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	-3.42%
Dividend growth years	1
Dividend payment date	2026-11-09
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	CAD 0.63
Dividend yield	2.94%
Ex-dividend date	2026-10-22
Last dividend	CAD 0.16
Payout ratio	69.86%
Shareholder yield	1.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 22.12
1D price change	-1.15%
1M price change	1.93%
1M total return	2.66%
1W price change	-4.12%
1W total return	-3.43%
1Y price change	7.87%
1Y return CAGR	11.14%
1Y total return	11.13%
20-day SMA	CAD 21.46
200-day SMA	CAD 21.28
3M price change	-15.91%
3M total return	-15.31%
3Y price change	29.37%
3Y return CAGR	12.79%
3Y total return	43.49%
50-day SMA	CAD 21.87
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 26.46
52-week high date	2026-07-21
52-week low	CAD 16.84
52-week low date	2026-03-30
6M price change	15.57%
6M total return	17.11%
All-time high	CAD 26.61
All-time high date	2022-12-12
All-time low	CAD 10.85
All-time low date	2024-12-23
Average true range (ATR)	CAD 0.39
Average volume	13.2K
Change from 52-week high	-18.75%
Change from 52-week low	27.67%
Change from all-time high	-18.56%
Change from all-time low	99.72%
Change from open	-0.23%
Day's gap	-0.92%
Dollar volume	CAD 492,974
High price	CAD 21.69
Low price	CAD 21.50
Monthly RSI	54.16
Open price	CAD 21.55
Position in 52-week range	0%
Previous close	CAD 21.75
Price vs 150-day SMA	-2.05%
Price vs 20-day SMA	0.98%
Price vs 200-day SMA	1.81%
Price vs 50-day SMA	-0.89%
Relative volume	1.74
RSI	48.76
Sharpe ratio	0.5
Sharpe ratio (3Y)	0.32
Sortino ratio	0.88
Sortino ratio (3Y)	0.62
Volume	22.9K
Weekly RSI	48.31
YTD price change	12.16%
YTD total return	15.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.41%
Short ratio	2 days

Deeper analysis on TSX/CVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/CVS report

Is a complete TSX/CVS research report available?

No complete published report is available for tsx/CVS (TSX/CVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/CVS (TSX/CVS)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/CVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/CVS

Frequently asked questions